Junfeng X. Zhang

301 Middle Yan Chang Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

ALOX5 mediates sunitinib resistance in renal cell carcinoma by reprogramming lipid metabolism through the p38/ERK/PPARα axis.

ALOX5 mediates sunitinib resistance in renal cell carcinoma by reprogramming lipid metabolism through the p38/ERK/PPARα axis.

Journal: International immunopharmacology

Published: April 14, 2026

ADAMTS9-AS2 Disrupts Docetaxel-Resistance in Castration-Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction.

ADAMTS9-AS2 Disrupts Docetaxel-Resistance in Castration-Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 23, 2025

USP21/YBX1/HIF1-α promotes the progression of prostate cancer.

USP21/YBX1/HIF1-α promotes the progression of prostate cancer.

Journal: Journal of translational medicine

Published: July 21, 2025

Correction: The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice.

Correction: The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice.

Journal: Scientific reports

Published: June 06, 2025

Re: Oncolytic Immunotherapy with Nivolumab in Muscle-invasive Bladder Cancer: A Phase 1b Trial.

Re: Oncolytic Immunotherapy with Nivolumab in Muscle-invasive Bladder Cancer: A Phase 1b Trial.

Journal: European urology

Published: May 27, 2025

The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression.

The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression.

Journal: MedComm

Published: July 19, 2024

CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer.

CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer.

Journal: Experimental & molecular medicine

Published: February 19, 2024

circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA.

circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA.

Journal: iScience

Published: November 20, 2023

Can uric acid affect the immune microenvironment in bladder cancer? A single-center multi-omics study.

Can uric acid affect the immune microenvironment in bladder cancer? A single-center multi-omics study.

Journal: Molecular carcinogenesis

Published: September 21, 2023

Comparative proteomic landscapes elucidate human preimplantation development and failure.

Comparative proteomic landscapes elucidate human preimplantation development and failure.

Journal: Cell

Published: July 03, 2023

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1.

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1.

Journal: Frontiers in oncology

Published: April 19, 2023

The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice.

The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice.

Journal: Scientific reports

Published: February 27, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026